Aarey Drugs & Pharmaceuticals rose 2.53% to Rs 107.25 at 13:19 IST on BSE after the company said it received first commercial export order from Germany.
The announcement was made during trading hours today, 9 May 2017.Meanwhile, the S&P BSE Sensex was up 71.13 points, or 0.24% to 29,997.28.
On the BSE, 1.50 lakh shares were traded in the counter so far, compared with average daily volumes of 1.41 lakh shares in the past one quarter. The stock had hit a high of Rs 108 and a low of Rs 105 so far during the day. The stock hit a record high of Rs 109.80 on 28 April 2017. The stock hit a 52-week low of Rs 36 on 10 May 2016.
The stock had underperformed the market over the past one month till 8 May 2017, rising 0.67% compared with 0.74% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 22.77% as against Sensex's 5.61% rise.
The small-cap company has equity capital of Rs 18.08 crore. Face value per share is Rs 10.
Also Read
Aarey Drugs & Pharmaceuticals said it received first commercial export order for 20 metric tons of Thiobromine from Germany. The order will be executed by 30 June 2017.
Net profit of Aarey Drugs & Pharmaceuticals rose 775% to Rs 1.75 crore on 51.60% rise in net sales to Rs 96.01 crore in Q3 December 2016 Q3 December 2015.
Aarey Drugs & Pharmaceuticals is one of the rising manufacturer representatives and suppliers of pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, APIs drugs, food colours and flavours.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
